Evaluation of seizure treatment in anti-LGI1, anti-NMDAR, and anti-GABA<sub>B</sub>R encephalitis

Marienke A.A.M. de Bruijn; Agnes van Sonderen; Marleen H. van Coevorden-Hameete; Anna E M Bastiaansen; Marco W.J. Schreurs; Rob P.W. Rouhl; Cees A. van Donselaar; Marian Majoie; Rinze F. Neuteboom; Peter A. E. Sillevis Smitt; Roland D. Thijs; Maarten J. Titulaer

doi:https://doi.org/10.1212/wnl.0000000000007475

doi.org/10.1212/wnl.0000000000007475

Evaluation of seizure treatment in anti-LGI1, anti-NMDAR, and anti-GABA_BR encephalitis

Marienke A.A.M. de Bruijn

11

,

Agnes van Sonderen

13

,

..., Maarten J. Titulaer

50

Neurology9.90

Volume: 92, Issue: 19

Published: May 7, 2019

Abstract

This nationwide cohort study evaluates seizure responses to immunotherapy and antiepileptic drugs (AEDs) in patients with anti-leucine-rich glioma-inactivated 1 (LGI1), anti-NMDA receptor (NMDAR), and anti-gamma-aminobutyric-acid B receptor (GABABR) encephalitis.Anti-LGI1, anti-NMDAR, and anti-GABABR encephalitis patients with new-onset seizures were included. Medical information about disease course, AEDs and immunotherapies used, effects, and...

Paper Fields

Paper Details

Title

Evaluation of seizure treatment in anti-LGI1, anti-NMDAR, and anti-GABA_BR encephalitis

DOI

doi.org/10.1212/wnl.0000000000007475

Published Date

May 7, 2019

Journal

Neurology

Volume

92

Issue

19

Citation AnalysisPro

You’ll need to upgrade your plan to Pro

Looking to understand the true influence of a researcher’s work across journals & affiliations?

Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.

Learn more

Notes

History

Evaluation of seizure treatment in anti-LGI1, anti-NMDAR, and anti-GABABR encephalitis

Evaluation of seizure treatment in anti-LGI1, anti-NMDAR, and anti-GABA_BR encephalitis